Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in…
Tag: Biosciences
SNAP Biosciences licenses Monarch's cell therapy tech
SNAP Biosciences licenses Monarch's cell therapy tech#SNAP #Biosciences #licenses #Monarch039s #cell #therapy #tech
Castle Biosciences amends charter, stockholders vote
Castle Biosciences amends charter, stockholders vote#Castle #Biosciences #amends #charter #stockholders #vote
Arcus Biosciences Stock May Be The Next To Fail (NYSE:RCUS)
This article was written by Follow At ELAM1, we empower financial professionals and investors with the…
Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company…
Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript
Pulse Biosciences, Inc. (PLSE) Q1 2025 Earnings Call Transcript #Pulse #Biosciences #PLSE #Earnings #Call #Transcript
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS
WILLOW BIOSCIENCES ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING VOTING RESULTS#WILLOW #BIOSCIENCES #ANNOUNCES #ANNUAL #GENERAL #SPECIAL #MEETING…
Neurocrine Biosciences: Valbenazine As Adjunctive Therapy Could Stage Comeback In 2025
Neurocrine Biosciences: Valbenazine As Adjunctive Therapy Could Stage Comeback In 2025 #Neurocrine #Biosciences #Valbenazine #Adjunctive #Therapy…
Aura Biosciences executive sells $39,319 in stock
Aura Biosciences executive sells $39,319 in stock#Aura #Biosciences #executive #sells #stock
Ideaya Biosciences: These Prices Are Probably Going To Look Cheap Sooner Than Later
Ideaya Biosciences: These Prices Are Probably Going To Look Cheap Sooner Than Later #Ideaya #Biosciences #Prices…
Genflow Biosciences enters AI gene therapy research deal
Genflow Biosciences enters AI gene therapy research deal#Genflow #Biosciences #enters #gene #therapy #research #deal
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space #Solid #Biosciences…
Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?
On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire…
Ventyx Biosciences chief scientific officer John Nuss sells $2,019 in shares
Ventyx Biosciences chief scientific officer John Nuss sells $2,019 in shares#Ventyx #Biosciences #chief #scientific #officer #John…
Ideaya Biosciences stock hits 52-week low at $16.95
Ideaya Biosciences stock hits 52-week low at $16.95#Ideaya #Biosciences #stock #hits #52week
Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript
Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript #Pulse #Biosciences #PLSE #Earnings #Call #Transcript
Junshi Biosciences Announces Toripalimab's Approval in Singapore
Junshi Biosciences Announces Toripalimab's Approval in Singapore#Junshi #Biosciences #Announces #Toripalimab039s #Approval #Singapore
Harmony Biosciences: A Compelling Risk-Reward Opportunity
Harmony Biosciences: A Compelling Risk-Reward Opportunity #Harmony #Biosciences #Compelling #RiskReward #Opportunity
Pacira BioSciences: Back On An Uptrend After Positive Developments
Pacira BioSciences: Back On An Uptrend After Positive Developments #Pacira #BioSciences #Uptrend #Positive #Developments
PCRX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Secu
PCRX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses…